semaglutide approved for obesity Weight Loss Drug Wegovy Can Also Reduce Risk of Heart Events Another Weight-Loss Trial Win for

However, as proposed in the new CBT for BED approach, these medications may be suitable for patients with BED associated with clinical obesity without an overvaluation of shape and weight, without a history of anorexia nervosa or bulimia nervosa, and other severe, unstable mental disorders, who have successfully adopted a regular eating pattern and significantly reduced binge-eating episodes

To explore how well GLP-1R agonists access various parts of the brain, Sechers team labeled various agonists with fluorescent tags so that when they administered the agonists to mice, they could see which areas of their brains lit up

Escalation phase breakdown The standard protocol starts low and increases every four weeks to minimize gastrointestinal side effects that rapid dose escalation can cause

But before you jump in, there are a few things doctors want you to know

It has a long half-life of approximately 7 days, allowing for once-daily dosing